Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-25

FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Sevelamer Carbonate from Aurobindo Pharma Limited, enabling its continued/expanded generic use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

SUPPL AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)